Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03132168 · ClinicalTrials.gov registry record · NA

Postoperative Delirium in Patients Undergoing Radical Cystectomy

A NA study, sponsored by Ohio State University.

Completed
Registry status
NA
Development phase
50
Enrollment target

NCT03132168 is a NA study that has completed, run by Ohio State University. The registered enrollment target is 50 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03132168, a NA study, has completed, sponsored by Ohio State University.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target

Study Summary

In this study, post-operative delirium will be measured in patients undergoing surgery for bladder resection, and associated microRNA biomarkers will be evaluated in patients considered delirious and non-delirious after surgery.

Interventions

  • PROCEDURE Blood Draw
  • BEHAVIORAL Assessments
  • OTHER Standardized Anesthetic Care

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2018-01-10
Est. Completion 2021-01-31
Phase NA

Sponsor

Ohio State University

552 total trials

What the Registry Record Tells You About NCT03132168

The ClinicalTrials.gov registry entry for NCT03132168 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Blood Draw is the first listed.

NCT03132168 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03132168 about?

NCT03132168 is a clinical study titled "Postoperative Delirium in Patients Undergoing Radical Cystectomy". In this study, post-operative delirium will be measured in patients undergoing surgery for bladder resection, and associated microRNA biomarkers will be evaluated in patients considered delirious and non-delirious after surgery.

What is the current status of trial NCT03132168?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2018-01-10. Estimated completion is 2021-01-31.

What interventions are being tested in trial NCT03132168?

The interventions under investigation include: Blood Draw (PROCEDURE), Assessments (BEHAVIORAL), Standardized Anesthetic Care (OTHER).

Who is sponsoring clinical trial NCT03132168?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.